Skip to content

Clinical trials

Oropharyngeal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Oropharyngeal Neoplasms Clear all

367 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20023
20033
20041
20054
20068
200713
20088
20097
201010
20117
201210
201311
201410
201511
201618
201717
201826
201926
202019
202122
202224
202328
202417
202525
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed138
Recruiting78
Active, not recruiting45
Unknown status42
Terminated30
Withdrawn19
Not yet recruiting13
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)28
M.D. Anderson Cancer Center26
Mayo Clinic11
Memorial Sloan Kettering Cancer Center10
Rigshospitalet, Denmark8
UNC Lineberger Comprehensive Cancer Center8
Emory University6
Abramson Cancer Center at Penn Medicine5
Fudan University4
Gustave Roussy, Cancer Campus, Grand Paris4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Oropharyngeal Neoplasms367
Head and Neck Neoplasms136
Mouth Neoplasms135
Laryngeal Neoplasms105
Hypopharyngeal Neoplasms100
Squamous Cell Carcinoma of Head and Neck95
Nasopharyngeal Neoplasms50
Carcinoma33
Uterine Cervical Neoplasms33
Carcinoma, Squamous Cell31

Trials

Showing 26 to 50 of 367. Each trial links to its page on Pharma Observatory.

267 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.